Invitrogen introduces new transfection reagent product
Invitrogen has introduced a new product into its line of transfection reagents, which the company claim will improve DNA delivery and lower toxicity.
Archives for September 7, 2006
New drug class encouraging in cancer treatment
A new drug class for the treatment of cancer has been hailed as a breakthrough by researchers in Denmark, who believe that patients with advanced breast cancer could stand to gain the most benefit from this new treatment.
R&D outsourcing dominated by pharma and biotech
A survey has revealed that the pharmaceutical and biotech industry are currently dominating the outsourcing scene in Europe, accounting for a quarter of all sub-contracting activity within the EU.